Calcium channel blocker use and risk of Parkinson's disease: a meta‐analysis

E-ISSN： 1099-1557|24|6|559-566

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.6, 2015-06, pp. : 559-566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macronutrients intake and risk of Parkinson's disease: A meta‐analysis

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 15, Iss. 5, 2015-05 ,pp. : 606-616

John Wiley & Sons Inc

Access to resources Recommend Favorite

Statin use and risk of gallstone disease: A meta‐analysis

HEPATOLOGY RESEARCH, Vol. 45, Iss. 9, 2015-09 ,pp. : 942-948

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apathy in Parkinson's disease: A systematic review and meta‐analysis

MOVEMENT DISORDERS, Vol. 30, Iss. 6, 2015-05 ,pp. : 759-769

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with meta‐analysis: the association between the use of calcium channel blockers and gastrointestinal bleeding

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 12, 2015-06 ,pp. : 1246-1255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose–response meta‐analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 14, Iss. 2, 2014-04 ,pp. : 430-439

John Wiley & Sons Inc

Access to resources Recommend Favorite